Tanta university hospital, Assuit University, Ainshams University
Tanta, Egypt
NCT Number: NCT04447534
we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Tanta, Egypt
we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19. As, zinc may be of value in these cases and may be of value in enhancing chloroquine effect.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Chloroquine or hydroxychloroquine
Other names: alexoquine, chloroquine, hydroquine
Zinc tablets
Time frame: 2 weeks
The number of patients with improvement or mortality.
Tanta University
Other
Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine in Treatment of COVID-19?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06821139
COVID, COVID - 19
Surrey, British Columbia, Canada
View Trial DetailsNCT03590327
Apathy, COVID
Little Rock, Arkansas, United States
View Trial DetailsNCT04447833
ARDS, Human, COVID
Uppsala, Sweden
View Trial DetailsNCT04367545
COVID, RT-ddPCR Multiplex
Rouen, France
View Trial Details